A Study to Evaluate Renal Safety of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Disease Due to Breast Cancer

NCT02716792 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

334

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain; Bone Neoplasms; Neoplasm Metastasis

Interventions

DRUG: Ibandronate

Sponsor

Hoffmann-La Roche